Federal hemp policy reshapes U.S. industry

PARAGRAPH 1 --- What happened: A federal policy change, set to take effect in late 2026, is expected to significantly reshape the U.S. hemp industry. This change, part of the Farm Bill, could force thousands of retailers to close, disrupting a fast-growing market. Meanwhile, President Trump eased federal marijuana laws, benefiting the entire cannabis industry, including 10 stocks like AdvisorShares Pure US Cannabis ETF. However, a hemp ban passed in November could derail a Medicare plan to reimburse patients for hemp-derived products like CBD. Tilray, a marijuana stock, briefly rallied on rescheduling news but gave back gains soon after.

PARAGRAPH 2 --- Market impact: The 2026 policy change threatens the survival of thousands of hemp retailers, potentially reshaping the industry's supply chain. Trump's announcement boosted the entire cannabis industry, with marijuana stocks like Tilray experiencing price volatility. The hemp ban could disrupt the CBD market, affecting companies involved in CBD production and distribution. Medicare's CBD reimbursement pilot could also be impacted.

PARAGRAPH 3 --- What to watch next: Investors should monitor the implementation of the 2026 federal policy change and its impact on hemp retailers. Upcoming regulatory decisions, such as the Justice Department's stance on marijuana rescheduling, will determine the cannabis industry's trajectory. The success of Medicare's CBD reimbursement pilot, despite the hemp ban, will also be a key catalyst to watch.